Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine Derivative - EP2914255

The patent EP2914255 was granted to Murray & Poole Enterprises on Jul 21, 2021. The application was originally filed on Nov 1, 2013 under application number EP13851803A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2914255

MURRAY & POOLE ENTERPRISES
Application Number
EP13851803A
Filing Date
Nov 1, 2013
Status
Granted And Under Opposition
Jun 18, 2021
Publication Date
Jul 21, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSApr 21, 2022D YOUNGADMISSIBLE
PHARMASCIENCEApr 20, 2022MAIWALDADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2128170
DESCRIPTIONUS2009312430
DESCRIPTIONUS2011178180
DESCRIPTIONWO2010138670
DESCRIPTIONWO2011022805
INTERNATIONAL-SEARCH-REPORTUS2006286108
INTERNATIONAL-SEARCH-REPORTUS2011190397
INTERNATIONAL-SEARCH-REPORTWO2007048004
INTERNATIONAL-SEARCH-REPORTWO2008131192
INTERNATIONAL-SEARCH-REPORTWO2010046628
OPPOSITIONWO2014066944
SEARCHCN1939290
SEARCHWO9215282

Non-Patent Literature (NPL) Citations (81) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALALI, FERAS Q.QANDIL, AMJADGHARAIBEH, AHMAD A.GHAWANMEH, ABDULLAHTAWAHA, KHALEDBURGESS, JASON P.SY, ARLENENAKANISHI, YUKAKROLL, DAVID J.OBERLIES, NICHOLAS H., "Colchicinoids from Colchicum crocifolium Boiss", Colchicaceae) Natural Product Research, (20100000), vol. 24, no. 2, pages 152 - 159
DESCRIPTION- BARTUSIK, DOROTATOMANEK, BOGUSLAWFALLONE, GINOLATTOVA, ERIKAPERREAULT, HELENETUSZYNSKI, JACK, Derivatives of thiocolchicine and its applications to CEM cells treatment using 19F Magnetic Resonance ex vivo Bioorganic Chemistry, (20100000), vol. 38, no. 1, pages 1 - 6
DESCRIPTION- BARTUSIK, DOROTATOMANEK, BOGUSLAWFALLONE, GINOLATTOVA, ERIKAPERREAULT, HELENETUSZYNSKI, JACK, "The efficacy of new colchicine derivatives and viability of the TLymphoblastoid cells in three-dimensional culture using 19F MRI and HPLCUV ex vivo", Bioorganic Chemistry, (20090000), vol. 37, no. 6, pages 193 - 201
DESCRIPTION- BENSEL, NICOLAS; LAGNOUX, DAVID; NIGGLI, VERENA; WARTMANN, MARKUS; REYMOND, JEAN-LOUIS, "New C(4)-Functionalized Colchicine Derivatives", a Versatile Multicomponent Electrophilic Aromatic Substitution Helvetica Chimica Acta, (20040000), vol. 87, no. 9, pages 2266 - 2272
DESCRIPTION- BOYER, FRANOIS-DIDIERDUBOIS, JOELLETHORET, SYLVIANEDAU, MARIE-ELISE TRAN HUUHANNA, ISSAM, Synthesis and tubulin-binding properties of new allocolchicinoids Bioorganic Chemistry, (20100000), vol. 38, no. 4, pages 149 - 158
DESCRIPTION- DIETRICH, ANDREAMUELLER, THOMASSCHOBERT, RAINERBIERSACK, BERNHARDEFFENBERGER, KATHARINAKNAUER, SEBASTIAN, "4-(3-Halo/amino-4,5-dimethoxyphenyI)-5-atyloxazoles and-N-methylimidazoles that are cytotoxic against combretastatin a resistant tumor cells and vascular disrupting", a cisplatin resistant germ cell tumor model Journal of Medicinal Chemistry, (20100000), vol. 53, no. 18, pages 6595 - 6602
DESCRIPTION- HUFFORD, CHARLES D.CAPRARO, HANS-GEORGBROSSI, ARNOLD., "13)C- and (1)HNMR. Assignments for Colchicine Derivatives", Helvetica Chimica Acta, (19800000), vol. 63, no. 1, pages 50 - 56
DESCRIPTION- HUFFORD, CHARLES D.CAPRARO, HANS-GEORGBROSSI, ARNOLD, "13)C- and (1)H-NMR. Assignments for Colchicine Derivatives", Helvetica Chimica Acta, (19800000), vol. 63, no. 1, pages 50 - 56, XP055188815
DESCRIPTION- JOHANSSON, EMMA M. V.DARBRE, TAMISREYMOND, JEAN-LOUISDUBOIS, JOELLE, "Glycopeptide dendrimer colchicine conjugates targeting cancer cells", Bioorganic and Medicinal Chemistry, (20100000), vol. 18, no. 17, pages 6589 - 6597, XP027218845
DESCRIPTION- KOUROUPIS, PAVLOSHANSEN, HANS-JURGEN, "From Colchicine and Some of Its Derivatives to 1,2,3,9,10-Pentamethoxybenzo[a]heptalenes", Helvetica Chimica Acta, (19950000), vol. 78, pages 1247 - 1277
DESCRIPTION- KOUROUPIS, PAVLOSKESSLER, JACQUELINEHANSEN, HANS-JUERGEN, "10-Alkyl-10-demethylcolchicines", Helvetica Chimica Acta, (19960000), vol. 79, pages 208 - 212
DESCRIPTION- KOUROUPIS, PAVLOSLINDEN, ANTHONYHANSEN, HANS-JUERGEN, "Synthesis of 4-Acetylcolchicine Helvetica", Chimica Acta, (19960000), vol. 79, pages 203 - 207
DESCRIPTION- KOUROUPIS, PAVLOSLINDEN, ANTHONYHANSEN, HANS-JUERGEN, Synthesis of 4-Acetylcolchicine Helvetica, Chimica Acta, (19960000), vol. 79, pages 203 - 207
DESCRIPTION- KOZAKA, TAKASHINAKAGAWA-GOTO, KYOKOSHI, QIANLAI, CHIN-YUBROSSI, ARNOLDLEE, KUO-HSIUNGHAMEL, ERNESTBASTOW, KENNETH F., "Antitumor agents 273. Design and synthesis of N-alkyl-thiocolchicinoids as potential antitumor agents", Bioorganic and Medicinal Chemistry Letters, (20100000), vol. 20, no. 14, pages 4091 - 4094, XP027103993
DESCRIPTION- MALYSHEVA, YULIA B.FEDOROV, ALEXEY YU.COMBES, SEBASTIENALLEGRO, DIANEPEYROT, VINCENTKNOCHEL, PAULGAVRYUSHIN, ANDREI E., Synthesis and biological evaluation of novel anticancer bivalent colchicine-tubulizine hybrids Bioorganic and Medicinal Chemistry, (20120000), vol. 20, no. 14, pages 4271 - 4278
DESCRIPTION- NIDORF et al., "Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Rective Protein Independent of Asprin and Atorvastatin in Patients With Stable Coronary Artery Disease", The American Journal of Cardiology, (20070315), vol. 99, no. 6, pages 805 - 807
DESCRIPTION- PATIL, SHIVAPUTRA A.WANG, JINLI, XIAOCHEN S.CHEN, JIANJUNHOSNI-AHMED, AMIRAPATIL, RENUKADEVILI, WEIMILLER, DUANE D.JONES, TERREIA S.SEIBEL, WILLIAM L., New substituted 4H-chromenes as anticancer agents Bioorganic and Medicinal Chemistry Letters, (20120000), vol. 22, no. 13, pages 4458 - 446
DESCRIPTION- QUINN, FRANK R.NEIMAN, ZOHARBEISLER, JOHN A., "Toxicity Quantitative Structure-Activity Relationships of Colchicines", Journal of Medicinal Chemistry, (19810000), vol. 24, no. 5, pages 636 - 639
DESCRIPTION- QUINN, FRANK R.NEIMAN, ZOHARBEISLER, JOHN A., Toxicity Quantitative Structure- Activity Relationships of Colchicines Journal of Medicinal Chemistry, (19810000), vol. 24, no. 5, pages 636 - 639
DESCRIPTION- SHARMA, SHUBHADARAVINDRA, RUDRAVAJHALABLANDEN, ADAM R.BANE, SUSANPOLIKS, BARBARACHIAUZZI, COLBY, "Characterization of the colchicine binding site on avian tubulin isotype 131/1", Biochemistry, (20100000), vol. 49, no. 13, pages 2932 - 2942
DESCRIPTION- STEFELY, JONATHAN A.MILLER, PATRICIA A.PETERSON, REBECCA J.MORASKI, GARRETT C.MILLER, MARVIN J.PALCHAUDHURI, RAHULHERGENROTHER, PAUL J., "N- ((l-benzyl-lH-1,2,3-triazol-4-yOmethyOarylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines", Journal of Medicinal Chemistry, (20100000), vol. 53, no. 8, pages 3389 - 3395
DESCRIPTION- SUN, LIMCPHAIL, ANDREW T.HAMEL, ERNESTLIN, CHII M.HASTIE, SUSAN B. et al., "Antitumor Agents. 139. Synthesis and Biological Evaluation of Thiocolchicine Analogs 5,6- Dihydro -6(S)- (acyloxy)- and 5,6- Dihydro-6(S)-(aroyloxy)methyl- 1,2,3-trimethoxy-9-(methylthio)-8H-cyclohepta[a]naphthalen-8-ones as Novel Cytotoxic and Antimitotic Agents", Journal of Medicinal Chemistry, (19930000), vol. 36, no. 5, pages 544 - 551
DESCRIPTION- SUN, LIMCPHAIL, ANDREW T.HAMEL, ERNESTLIN, CHII M.HASTIE, SUSAN B. et al., "Antitumor Agents. 139. Synthesis and Biological Evaluation of Thiocolchicine Analogs 5,6-Dihydro-6(S)-(acyloxy)- and 5,6- Dihydro-6(S)-(aroyloxy)methyl-1,2,3- trimethoxy-9-(methylthio)-8H-cyclohepta[a]naphthalen-8-ones as Novel Cytotoxic and Antimitotic Agents", Journal of Medicinal Chemistry, (19930000), vol. 36, no. 5, pages 544 - 551
DESCRIPTION- NICOLAUS, NORMANNEUDOERFL, JOERG-MARTINSCHMALZ, HANS-GUENTHERZAPKE, JANETOSCHKINAT, HARTMUTRIESTERER, PHILIPPPROKOP, ARAM, "Azides derived from colchicine and their use in library synthesis: A practical entry to new bioactive derivatives of an old natural drug", ChemMedChem, (20100000), vol. 5, no. 5, doi:10.1002/cmdc.201000063, pages 661 - 665, XP055188648
DESCRIPTION- CHANG, DONG-JOJUNG, JONG-WHAAN, HONGCHANSUH, YOUNG-GERYOON, EUN- YOUNGLEE, GEON-BONGKIM, SOON-OKKIM, WAN- JOOKIM, YOUNG-MYEON, "Design, synthesis and identification of novel colchicine-derived immunosuppressant", Bioorganic and Medicinal Chemistry Letters, (20090000), vol. 19, no. 15, doi:10.1016/j.bmcl.2009.05.054, pages 4416 - 4420, XP029120764
DESCRIPTION- YANG, BAIYUANZHU, ZHIQING C.GOODSON, HOLLY V.MILLER, MARVIN J., "Syntheses and biological evaluation of ring-C modified colchicine analogs", Bioorganic and Medicinal Chemistry Letters, (20100000), vol. 20, no. 12, doi:10.1016/j.bmcl.2010.03.056, pages 3831 - 3833, XP029212938
DESCRIPTION- NICOLAOU, K. C.VALIULIN, ROMAN A.POKORSKI, JONATHAN K.CHANG, VICKICHEN, JASON S., "Bio-inspired synthesis and biological evaluation of a colchicine-related compound library", Bioorganic and Medicinal Chemistry Letters, (20120000), vol. 22, no. 11, doi:10.1016/j.bmcl.2012.04.007, pages 3776 - 3780, XP028423362
DESCRIPTION- GABRIELYAN et al., "Comparative effects of losartan and losartan colchicines combination therapy in unstable angina patients with hyperuricaemia", European Journal of Echocardiography, (20061201), vol. 7, doi:10.1016/S1525-2167(06)60306-5, page S83, XP005807173
DESCRIPTION- DANIELI, BRUNOGIARDINI, ALESSANDRALESMA, GIORDANOPASSARELLA, DANIELEPERETTO, BRUNOSACCHETTI, ALESSANDROSILVANI, ALESSANDRAPRATESI, GRAZIELLAZUNINO, FRANCO, "Thiocolchicine-Podophyllotoxin Conjugates: Dynamic Libraries Based on Disulfide Exchange Reaction", Journal of Organic Chemistry, (20060000), vol. 71, no. 7, doi:10.1021/jo052677g, pages 2848 - 2853, XP002422429
EXAMINATION- E W Chia ET AL, "Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine : Colchicine inhibits superoxide production in gout", BRITISH JOURNAL OF PHARMACOLOGY, UK, (20080301), vol. 153, no. 6, doi:10.1038/bjp.2008.20, ISSN 0007-1188, pages 1288 - 1295, XP055572571
EXAMINATION- N. Schlesinger ET AL, "Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study", Annals of the Rheumatic Diseases, GB, (20110701), vol. 70, no. 7, doi:10.1136/ard.2010.144063, ISSN 0003-4967, pages 1264 - 1271, XP055572564
OPPOSITION- Anonymous, "Anthera halts late-stage heart drug trial, shares tank", (20120309), pages 1 - 3, Reuters, URL: https://jp.reuters.com/article/us-antherapharmaceuticals-brief/anthera-halts-late-stage-heart-drug-trial-shares-tank-idUSBRE8281EC20120309, (20231127), XP093105942
OPPOSITION- Anonymous, "ARTG search", Australian Government- Department of Health, (20120531), pages 1 - 2, XP055917945
OPPOSITION- Anonymous, "History of Changes for Study: NCT01327846 Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) (CANTOS)", Clinical trials, (20120814), no. NCT01327846 , pages 1 - 92, XP093105970
OPPOSITION- Anonymous, "LoDoCo Study: The effect of low dose colchicine on the natural history of atherosclerosis", ANZCTR - Australian New Zealand Clinical Trials Registry, (20100413), pages 1 - 5, XP055917955
OPPOSITION- Bauriedel G, Heimerl J, Beinert T, Welsch U, Höfling B, "Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy", Coronary Artery Disease, GB , (19940601), vol. 5, no. 6, ISSN 0954-6928, pages 531 - 539, XP093106955
OPPOSITION- Crittenden Daria B, Et Al, "Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout", J Rheumatol., (20120701), vol. 39, no. 7, pages 1458 - 1464, XP055916642
OPPOSITION- Currier Jesse Y, Thomas K. Pow, Anne C. Minihan, Christian C. Haudenschild, David P. Faxon, Thomas J. Ryan, "Colchicine Inhibits Restenosis After Iliac Angioplasty in the Atherosclerotic Rabbit", Circulation, US , (19891001), vol. 80, no. 4, ISSN 0009-7322, pages II - II-66, XP093106961
OPPOSITION- Hollander William, Kramsch Dieter M, Franzblau Carl, Paddock John, Colombo Marilyn A, "Suppression of Atheromatous Fibrous Plaque Formation by Antiproliferative and Anti-inflammatory Drugs", Circulation research, (19740501), pages I - I-141, XP093106899
OPPOSITION- Judkins Christopher, "Low Dose Colchicine: Vascular Reactivity and the Inflammatory Cascade (The Effect of Colchicine on Flow Mediated Dilation and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease) ", Thesis, (20110101), pages 1 - 138, XP093104849
OPPOSITION- Judkins Christopher, "Low Dose Colchicine: Vascular Reactivity and the Inflammatory Cascade (The Effect of Colchicine on Flow Mediated Dilation and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease)", Thesis, (20110101), pages 1 - 138, XP093106796
OPPOSITION- Kiraz S, Ertenli I, Arici M, Calgüneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S, "Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever", Clinical and experimental Rheumatology, IT , (19980101), vol. 16, no. 6, ISSN 0392-856X, pages 721 - 724, XP093106966
OPPOSITION- Mcauley David, "STATINS (HMG-COA REDUCTASE INHIBITORS)", GlobalRPH - The Clinician's Ultimate Reference, GlobalRPH, (20180415), pages 1 - 2, GlobalRPH - The Clinician's Ultimate Reference, URL: https://globalrph.com/drugs/statins-hmg-coa-reductase-inhibitors/, (20240213), XP093130907
OPPOSITION- Ridker Paul M, "C-Reactive Protein, Inflammation, and Cardiovascular Disease", Current Issues in Cardiology, (20050101), vol. 35, no. 5, pages 384 - 386, XP093105957
OPPOSITION- Wojcicki Jerzy, Hinek Aleksander, Jaworska Maria, Samochowiec Leonidas , "The effect of colchicine on the development of experimental atherosclerosis in rabbits", Polish Journal of Pharmacology and Pharmacy, PL , (19860101), ISSN 0301-0244, pages 343 - 348, XP093106909
OPPOSITION- Ridker Paul M, Jose Torres , "Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005", JAMA, (20060517), vol. 295, no. 19, doi:10.1001/jama.295.19.2270, pages 2270 - 2274, XP093106841
OPPOSITION- Paul M Ridker, Tom Thuren, Andrew Zalewski , Peter Libby, "Interleukin-1 inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)", American Heart Journal, AMSTERDAM, NL , (20110620), vol. 162, no. 4, doi:10.1016/j.ahj.2011.06.012, ISSN 0002-8703, pages 597 - 605, XP028308077
OPPOSITION- Nidorf, M. Thompson, P.L., "Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Reactive Protein Independent of Aspirin and Atorvastatin in Patients With Stable Coronary Artery Disease", AMERICAN JOURNAL OF CARDIOLOGY., CAHNERS PUBLISHING CO., NEWTON, MA,, US, US , (20070316), vol. 99, no. 6, doi:10.1016/j.amjcard.2006.10.039, ISSN 0002-9149, pages 805 - 807, XP005919633
OPPOSITION- Nidorf, M. Thompson, P.L., "Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Reactive Protein Independent of Aspirin and Atorvastatin in Patients With Stable Coronary Artery Disease", AMERICAN JOURNAL OF CARDIOLOGY, US , (20070316), vol. 99, no. 6, doi:10.1016/j.amjcard.2006.10.039, ISSN 0002-9149, pages 805 - 807, XP005919633
OPPOSITION- Nidorf, M. Blanton, C. Thompson, P.L., "The Effect of Low Dose Colchicine on hs-CRP in Patients with Stable Coronary Artery Disease (CAD) Independent of Aspirin and Statin Therapy", Heart, Lung and Circulation, AMSTERDAM, NL , (20070101), vol. 16, doi:10.1016/j.hlc.2007.06.180, ISSN 1443-9506, page S70, XP022142842
OPPOSITION- C. Judkins, P. Thompson, M. Nidorf, B. McQuillan, "LoDoCo: LOw DOse COlchicine in Stable Coronary Artery Disease and the Effect on hs-CRP and Brachial Flow Mediated Dilation", Heart, Lung and Circulation, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20110801), vol. 20, no. Suppl. 2, doi:10.1016/j.hlc.2011.05.092, ISSN 1443-9506, page S36, XP055917957
OPPOSITION- Rosenson Robert S.; Hislop Colin; Elliott Michael; Stasiv Yuri; Goulder Michael; Waters David, "Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients", Journal of the American College of Cardiology, AMSTERDAM, NL, (20100928), vol. 56, no. 14, doi:10.1016/j.jacc.2010.06.015, ISSN 0735-1097, pages 1079 - 1088, XP029648848
OPPOSITION- Vogel Robert A, James S Forrester , "Cooling Off Hot Hearts: A Specific Therapy for Vulnerable Plaquer", Journal of the American College of Cardiology, AMSTERDAM, NL, (20130129), vol. 64, no. 4, doi:10.1016/j.jacc.2012.10.026, ISSN 0735-1097, pages 411 - 412, XP093106813
OPPOSITION- Stefan M. Nidorf et al, "Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease", Journal of the American College of Cardiology, (20130101), vol. 61, no. 4, doi:10.1016/j.jacc.2012.10.027, ISSN 07351097, pages 404 - 410, XP055147314
OPPOSITION- Stefan M. Nidorf, John W. Eikelboom, Charley A. Budgeon, Peter L. Thompson, "Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease", Journal of the American College of Cardiology, Elsevier, (20130101), vol. 61, no. 4, doi:10.1016/j.jacc.2012.10.027, ISSN 07351097, pages 404 - 410, XP055147314
OPPOSITION- Libby Peter; Ridker Paul M; Hansson Göran K, "Progress and challenges in translating the biology of atherosclerosis", Nature, (20110501), vol. 473, no. 7347, doi:10.1038/nature10146, pages 317 - 325, XP037159435
OPPOSITION- Ross Russel, "Atherosclerosis - An inflammatory disease", The New England journal of medicine, US , (19990114), vol. 340, no. 2, doi:10.1056/NEJM199901143400207, ISSN 0028-4793, pages 115 - 126, XP001094954
OPPOSITION- Ridker Paul M, Danielson Eleanor, Fonseca Francisco A.H., Genest Jacques, Gotto Antonio M., Kastelein John J.P., Koenig Wolfgang, Libby Peter, Lorenzatti Alberto J., Macfadyen Jean G., Nordestgaard Børge G., Shepherd James, Willerson James T., Glynn Robert J., "Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein", The New England journal of medicine, US , (20081120), vol. 359, no. 21, doi:10.1056/NEJMoa0807646, ISSN 0028-4793, pages 2195 - 2207, XP093105950
OPPOSITION- Nidorf Stefan M., Fiolet Aernoud T.L., Mosterd Arend, Eikelboom John W., Schut Astrid, Opstal Tjerk S.J., The Salem H.K., Xu Xiao-Fang, Ireland Mark A., Lenderink Timo, Latchem Donald, Hoogslag Pieter, Jerzewski Anastazia, Nierop Peter, Whelan Alan, Hendriks Randall, Swart Henk, Schaap Jeroen, Kuijper Aaf F.M., Van Hessen Maarten W.J., Saklani Pradyot, Tan Isabel, Thompson Angus G., Morton Allison, Judkins Chris, Bax Willem A., Dirksen Maurits, Alings Marco, Hankey Graeme J., Budgeon Charley A., Tijssen Jan G.P., Cornel Jan H., Thompson Peter L., "Colchicine in Patients with Chronic Coronary Disease", The New England journal of medicine, US , (20201105), vol. 383, no. 19, doi:10.1056/NEJMoa2021372, ISSN 0028-4793, pages 1838 - 1847, XP093106806
OPPOSITION- Hansson G.K., "Inflammation, Atherosclerosis, and Coronary Artery Disease", The New England journal of medicine, US , (20050421), vol. 352, no. 16, doi:10.1056/NEJMra043430, ISSN 0028-4793, pages 1685 - 1695, XP003014526
OPPOSITION- Libby Peter, "Mechanisms of acute coronary syndromes and their implications for therapy.", New England Journal of Medicine, US , (20130523), vol. 368, no. 21, doi:10.1056/NEJMra1216063, ISSN 1533-4406, pages 2004 - 2014, XP009187335
OPPOSITION- Anand S. S., Yusuf S., "C-reactive protein is a bystander of cardiovascular disease", European Heart Journal, GB , (20100901), vol. 31, no. 17, doi:10.1093/eurheartj/ehq242, ISSN 0195-668X, pages 2092 - 2096, XP093106826
OPPOSITION- Casas J. P., Shah T., Hingorani A. D., Danesh J., Pepys M. B., "C‐reactive protein and coronary heart disease: a critical review", Journal of internal medicine, GB , (20081001), vol. 264, no. 4, doi:10.1111/j.1365-2796.2008.02015.x, ISSN 0954-6820, pages 295 - 314, XP093106822
OPPOSITION- Ridker Paul M., "Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)", Journal of thrombosis and haemostasis, (20090701), vol. 7, doi:10.1111/j.1538-7836.2009.03404.x, ISSN 1538-7836, pages 332 - 339, XP093105985
OPPOSITION- Zhang, Doherty, Leeb, Alekseeva, Arden, Bijlsma, Dincer, Dziedzic, Hauselmann, Herrero Beaumont, Kaklamanis, Lohmander, Maheu, Martin Mola, Pavelka, Punzi, Reiter, Sautner, Smolen, Verbruggen, Zimmermann Gorska, "EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)", Annals of the Rheumatic Diseases, British Medical Association, GB, GB , (20070301), vol. 66, no. 3, doi:10.1136/ard.2006.062091, ISSN 0003-4967, pages 377 - 388, XP009509882
OPPOSITION- N. Schlesinger, E. Mysler, H.-Y. Lin, M. De Meulemeester, J. Rovensky, U. Arulmani, A. Balfour, G. Krammer, P. Sallstig, A. So, "Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study", Annals of the Rheumatic Diseases, British Medical Association, GB, GB , (20110701), vol. 70, no. 7, doi:10.1136/ard.2010.144063, ISSN 0003-4967, pages 1264 - 1271, XP055572564
OPPOSITION- Anonymous, "Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data", BMJ, (20110215), doi:10.1136/bmj.d548, pages 1 - 8, XP093106835
OPPOSITION- Wesley, Meng Xiaoping, Godin Denis, Galis Zorina S, "Extracellular Matrix Modulates Macrophage Functions Characteristic to Atheroma : Collagen Type I Enhances Acquisition of Resident Macrophage Traits by Human Peripheral Blood Monocytes In Vitro", Translational Sciences, (19980301), vol. 18, no. 3, doi:10.1161/01.ATV.18.3.432, ISSN 1079-5642, pages 432 - 440, XP093106914
OPPOSITION- Libby Peter, Okamoto Yoshihisa, Rocha Viviane Z., Folco Eduardo, "Inflammation in Atherosclerosis: Transition From Theory to Practice : Transition From Theory to Practice", CIRCULATION JOURNAL, JAPANESE CIRCULATION SOCIETY, KYOTO, JP, JP , (20100101), vol. 74, no. 2, doi:10.1253/circj.CJ-09-0706, ISSN 1346-9843, pages 213 - 220, XP055917936
OPPOSITION- Perico Norberto, Ostermann Daniel, Bontempelli Mario, Morigi Marina, Amuchastegui Susana, Zoja Carla, Akalin Enver, Sayegh Mohamed H, Remuzzi2 Giuseppe, Amuchastegul S, Remuzzi G, Remuni G, "Coichicine Interferes with L-Selectin and Leukocyte Function-Associated Antigen-i Expression on Human I Lym phocytes a nd In h ibits I Cell", Journal of the American Society of Nephrology, (19960401), vol. 7, no. 4, doi:10.1681/ASN.V74594, pages 594 - 601, XP093106953
OPPOSITION- Cerquaglia C., Diaco M., Nucera G., Regina M., Montalto M., Manna R., "Pharmacological and Clinical Basis of Treatment of Familial Mediterranean Fever (FMF) with Colchicine or Analogues: An Update", Current Drug targets - Inflammation and & Allegry, NL , (20050101), vol. 4, no. 1, doi:10.2174/1568010053622984, ISSN 1568-010X, pages 117 - 124, XP093106962
OPPOSITION- Yüksel Şahru, Ayvazyan Lilit, Gasparyan Armen Yuri, "Familial Mediterranean Fever as an Emerging Clinical Model of Atherogenesis Associated with Low-Grade Inflammation", The Open Cardiovascular Medicine Journal, (20100223), vol. 4, no. 1, doi:10.2174/1874192401004010051, ISSN 1874-1924, pages 51 - 56, XP093105928
OPPOSITION- Shishehbor Mehdi H., Hazen Stanley L., "JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?", Cleveland clinic journal of medicine, US , (20090101), vol. 76, no. 1, doi:10.3949/ccjm.75a.08105, ISSN 0891-1150, pages 37 - 44, XP093105963
SEARCH- LAGRUE G ET AL, "Effect of colchicine on atherosclerosis. I. Clinical and biological studies", CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, BASEL, CH, (19850101), vol. 3, no. 5, ISSN 0252-1164, pages 221 - 225, XP009190020 [X] 1,3-6,10-15 * title, abstract, last § of discussion * [Y] 1-15
SEARCH- O'KEEFE J H JR ET AL, "INEFFECTIVENESS OF COLCHICINE FOR THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER, NEW YORK, NY, US, (19920101), vol. 19, no. 7, ISSN 0735-1097, pages 1597 - 1600, XP008069957 [A] 1-15 * abstract, title *
SEARCH- NINA C RAJU ET AL, "Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial", JOURNAL OF THROMBOSIS AND THROMBOLYSIS, KLUWER ACADEMIC PUBLISHERS, BO, (20110915), vol. 33, no. 1, doi:10.1007/S11239-011-0637-Y, ISSN 1573-742X, pages 88 - 94, XP035001736 [A] 1-15 * title, abstract *
SEARCH- DINA M SPARANO ET AL, "Pericarditis and Pericardial Effusion: Management Update", CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, CURRENT SCIENCE INC, NEW YORK, (20111012), vol. 13, no. 6, doi:10.1007/S11936-011-0151-8, ISSN 1534-3189, pages 543 - 555, XP019972043 [X] 1,5,6,8,10-15 * p. 546, last §; table 1 * [Y] 1-15
SEARCH- NAKAMURA Y ET AL, "Role of microtubules in ischemic preconditioning against myocardial infarction", CARDIOVASCULAR RESEARCH, OXFORD UNIVERSITY PRESS, GB, (20041101), vol. 64, no. 2, doi:10.1016/J.CARDIORES.2004.07.013, ISSN 0008-6363, pages 322 - 330, XP004600509 [A] 1-15 * title, abstract *
SEARCH- STEFAN M. NIDORF ET AL, "Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, (20130101), vol. 61, no. 4, doi:10.1016/j.jacc.2012.10.027, ISSN 0735-1097, pages 404 - 410, XP055147314 [XP] 1-15 * the whole document * [Y] 1-15
SEARCH- GABRIELYAN ET AL, "516 Comparative effects of losartan and losartan colchicines combination therapy in unstable angina patients with hyperuricaemia", EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, HARCOURT PUBLISHERS, EDINBURGH, GB, (20061201), vol. 7, doi:10.1016/S1525-2167(06)60306-5, ISSN 1525-2167, page S83, XP005807173 [X] 1,3-8,10-15 * the whole document * [Y] 1-15
SEARCH- N. SCHLESINGER ET AL, "Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study", ANNALS OF THE RHEUMATIC DISEASES, GB, (20110701), vol. 70, no. 7, doi:10.1136/ard.2010.144063, ISSN 0003-4967, pages 1264 - 1271, XP055272366 [Y] 1-15 * p. 1270, col. 2, third full § *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents